Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-2262167 is a potent S1P1 agonist, as effective as fingolimod in collagen-induced arthritis models, and shows good preclinical pharmacokinetic properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | GSK-2262167 is a potent S1P1 agonist, as effective as fingolimod in collagen-induced arthritis models, and shows good preclinical pharmacokinetic properties. |
Synonyms | GSK-2262167, GSK2262167, GSK 2262167 |
Molecular Weight | 469.497 |
Formula | C25H26N4NaO4 |
CAS No. | 1165923-54-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-2262167 sodium 1165923-54-5 GSK 2262167 sodium GSK2262167 sodium GSK-2262167 GSK2262167 GSK 2262167 inhibitor inhibit